Last €74.66 EUR
Change Today +0.153 / 0.21%
Volume 233.0K
MOR On Other Exchanges
As of 2:20 PM 02/27/15 All times are local (Market data is delayed by at least 15 minutes).

Executive Profile*

Walter A. Blattler Ph.D.

Member of Supervisory Board and Chairman of Scientific & Technology Committee, Morphosys AG
AgeTotal Calculated CompensationThis person is connected to 5 board members in 1 different organizations across 2 different industries.

See Board Relationships


Dr. Walter A. Blattler, Ph.D, served as an Executive Vice President of Science and Technology at ImmunoGen, Inc. since 1996. Prior to joining ImmunoGen at its newly established laboratories, Dr. Blattler held various positions at the Dana-Farber Cancer Institute, Harvard Medical School, in Boston. In 1987 he joined ImmunoGen Inc., as Vice President and subsequently Senior Vice President, Research and Development. He has been a Member of Supervisory Board at Morphosys ...

Read Full Background

Corporate Headquarters*

Lena-Christ-Strasse 48
Martinsried, Bavaria 82152


Phone: 49 8989 9270
Fax: 49 89 8992 7222

Board Members Memberships*

Former Executive Vice President of Science and Technology and Director


Unknown/Other Education
Eidgenössische Technische Hochschule Zürich
MS 1973
Eidgenössische Technische Hochschule Zürich
PhD 1978
Eidgenössische Technische Hochschule Zürich

Other Affiliations*

Annual Compensation*

There is no Annual Compensation data available.

Stock Options*

There is no Stock Options data available.

Total Compensation*

Total Annual Cash Compensation€60,160
Total Calculated Compensation€60,160
*Data is at least as current as the most recent Definitive Proxy.

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
MOR:GR €74.66 EUR +0.153


Gustav A. Christensen Chief Executive Officer, President and Director
Dyax Corp.
Daniel M. Junius Chief Executive Officer, President and Director
ImmunoGen, Inc.
John W. Varian Chief Executive Officer, President and Director
XOMA Corporation
Jan G. J. van de Winkel Ph.D.Co-Founder, Chief Executive Officer and President
Genmab A/S
Edwin Moses Ph.D.Chief Executive Officer and Director
Ablynx NV
Compensation as of Fiscal Year 2013.

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact MORPHOSYS AG, please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at